drugset / Trial / NCT03201601

Evaluation of the Mixture Myoinositol:D-chiro-inositol 3.6:1 in Women With Polycystic Ovary Syndrome

NCT03201601

Phase 2/3 Completed 60 enrolled Biosearch S.A.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of the present study is to evaluate the effect of increasing the proportion of D-chiro-inositol (DCI) in a combination with myo-inositol (MYO) in improving fertility in women with polycystic ovarian syndrome (PCOS). Sixty women diagnosed with PCOS will randomly take twice a day for 12 weeks a capsule containing 550 mg of myo-inositol and 150 mg of D-chiro-inositol or capsules containing 550 mg of myo-inositol and 13.8 mg of D-chiro-inositol.

Timeline

Start
2016-02
Primary completion
2017-05
Completion
2017-05-05

Drugs

EvaluationDrugModalityDoseRoute
Subject D-chiro-inositol Small molecule 13.8 mg
Subject D-chiro-inositol Small molecule 150 mg
Subject Inositol Small molecule 550 mg